These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3523271)

  • 1. [Prospective trial of treating aneurysmal meningeal hemorrhage by delayed operation under cover of antifibrinolytic therapy].
    Irthum B; Chazal J; Commun C; Chabannes J; Janny P
    Neurochirurgie; 1986; 32(2):122-8. PubMed ID: 3523271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose tranexamic acid combined with aprotinin in the pre-operative management of ruptured intracranial aneurysms.
    Spallone A; Pastore FS; Rizzo A; Guidetti B
    Neurochirurgia (Stuttg); 1987 Nov; 30(6):172-6. PubMed ID: 2447515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of vasospasm with operative results in ruptured aneurysms].
    Nitta M; Nagai H; Hara M; Tanaka H; Shintani A; Takagi T; Hori H; Ito H; Maeda S
    No Shinkei Geka; 1982 Aug; 10(8):823-9. PubMed ID: 7133303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
    Fodstad H; Forssell A; Liliequist B; Schannong M
    Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the treatment of aneurysmal meningeal hemorrhage with antifibrinolytic agents, calcium inhibitors and maintenance of effective blood volume].
    Gutknecht JL; Irthum B; Cavaroc G; Halberstadt J; Planchon E; Greil P; Berard JP
    Agressologie; 1990 Jun; 31(6):340-3. PubMed ID: 2285104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage.
    Kassell NF; Haley EC; Torner JC
    Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intracranial aneurysms and subarachnoid hemorrhage in children and adolescents].
    Mazza C; Pasqualin A; Da Pian R; Pezzotta S
    Minerva Med; 1986 Jun; 77(25):1145-51. PubMed ID: 3725140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on rebleeding of cerebral anuerysms--with special references to the warning signs of rebleeding and antifibrinolytic treatment during waiting time for surgery (author's transl)].
    Tamaki N; Kusunoki T; Oi S; Taomoto K; Matsumoto S
    No Shinkei Geka; 1975 Aug; 3(8):647-54. PubMed ID: 1238945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease.
    Sundt TM; Whisnant JP
    N Engl J Med; 1978 Jul; 299(3):116-22. PubMed ID: 661871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
    Alvarez Garijo JA; Vilches JJ; Aznar JA
    J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deferred surgery of cerebral aneurysms. Long-term follow-up in 103 cases].
    Rodriguez y Baena R; Rainoldi F; Gaetani P; Bonezzi C; Paoletti P
    Minerva Med; 1986 Jun; 77(24):1111-8. PubMed ID: 3725137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the management of saccular aneurysms.
    Kassell NF; Drake CG
    Neurol Clin; 1983 Feb; 1(1):73-86. PubMed ID: 6680167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy and prognosis of subarachnoid hemorrhage due to rupture of a cerebral aneurysm].
    Seiler RW
    Schweiz Med Wochenschr; 1983 Feb; 113(6):202-7. PubMed ID: 6836246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
    Tsementzis SA; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 102(1-2):1-10. PubMed ID: 2407050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.